Eli Lilly says it plans to buy cancer-drug developer ImClone Systems for $70 a share, or about $6.5 billion, in an all-cash deal that is not subject to any financing conditions.

Sam Waksal, the former chief executive of ImClone Systems Inc <IMCL.H>, whose insider trading scam sent him and Martha Stewart to prison, on Monday announced an acquisition meant to catapult him ...

INDIANAPOLIS — Eli Lilly &amp; Co.'s winning bid of more than $6 billion for cancer drug maker ImClone Systems means a billion-dollar payday for former rival bidder Bristol-Myers, and ...

Eli Lilly is to take over ImClone Systems after the companies ended speculation and agreed a definitive merger deal where drug giant Lilly will pay out $6.5 billion for the biopharmaceutical company – ...

Lilly to Acquire ImClone Systems in $6.5 Billion Transaction Creates a Global Leader in Oncology Biopharmaceuticals Boosts Oncology Pipeline With Up to Three Promising Targeted Therapies in Phase ...

INDIANAPOLIS — Eli Lilly & Co. has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand Lilly’s cancer treatment pipeline a few years ...

NDIANAPOLIS | Eli Lilly & Co.'s winning bid of more than $6 billion for cancer drugmaker ImClone Systems means a billion-dollar payday for former rival bidder Bristol-Myers and vindication for ...

ImClone Systems remains silent on its secret bidder, but speculation over pharmaceutical giant Eli Lilly 's interest could continue pushing the biotech company's stock higher today. New York-based ...

The escalating squabble between Bristol-Myers Squibb (BMY) and ImClone Systems (IMCL) over ownership of the potentially valuable Erbitux follow-on, IMC-11F8, is likely to be a big factor in ...

Biotechnology company ImClone Systems Inc. said Wednesday that it is considering a buyout offer worth $70 per share from an unidentified large pharmaceutical company and rejected a $60-per-share ...

ImClone Systems chairman Carl Icahn today said the biotech has rejected Bristol-Myers Squibb's $4.3 billion bid as too low, but said the company has received a second, higher offer from a large ...